CREO MEDICAL GRP LS-001
CREO MEDICAL GRP LS-001 operates in various business sectors.
Market Cap & Net Worth: CREO MEDICAL GRP LS-001 (1RC)
CREO MEDICAL GRP LS-001 (F:1RC) has a market capitalization of $1.43K (€1.39K) as of March 19, 2026. Listed on the F stock exchange, this Germany-based company holds position #47692 globally and #8007 in its home market, demonstrating a 4.23% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying CREO MEDICAL GRP LS-001's stock price €0.15 by its total outstanding shares 9392 (9.39K).
CREO MEDICAL GRP LS-001 Market Cap History: 2021 to 2026
CREO MEDICAL GRP LS-001's market capitalization history from 2021 to 2026. Data shows change from $16.29K to $1.43K (-40.75% CAGR).
CREO MEDICAL GRP LS-001 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how CREO MEDICAL GRP LS-001's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 1RC by Market Capitalization
Companies near CREO MEDICAL GRP LS-001 in the global market cap rankings as of March 19, 2026.
Key companies related to CREO MEDICAL GRP LS-001 by market ranking:
- Ha Long Investment & Consulting JSC (VN:HID): Ranked #47683 globally with a market cap of $1.46K USD ( ₫37.21 Million VND).
- Blackrock Smaller Companies Trust PLC (LSE:BRSC): Ranked #47684 globally with a market cap of $1.46K USD ( GBX12.03 Million GBX).
- Quantum Helium Limited (LSE:QHE): Ranked #47693 globally with a market cap of $1.46K USD ( GBX11.99 Million GBX).
- NFI Octava SA (WAR:08N): Ranked #47694 globally with a market cap of $1.46K USD ( zł6.06K PLN).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #47683 | Ha Long Investment & Consulting JSC | VN:HID | $1.46K | ₫3900.00 |
| #47684 | Blackrock Smaller Companies Trust PLC | LSE:BRSC | $1.46K | GBX1256.00 |
| #47693 | Quantum Helium Limited | LSE:QHE | $1.46K | GBX0.03 |
| #47694 | NFI Octava SA | WAR:08N | $1.46K | zł0.66 |
CREO MEDICAL GRP LS-001 Historical Marketcap From 2021 to 2026
Between 2021 and today, CREO MEDICAL GRP LS-001's market cap moved from $16.29K to $ 1.43K, with a yearly change of -40.75%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €1.43K | +39.62% |
| 2025 | €1.02K | -50.00% |
| 2024 | €2.04K | -49.04% |
| 2023 | €4.01K | +48.57% |
| 2022 | €2.70K | -83.43% |
| 2021 | €16.29K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of CREO MEDICAL GRP LS-001 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.43K USD |
| MoneyControl | $1.43K USD |
| MarketWatch | $1.43K USD |
| marketcap.company | $1.43K USD |
| Reuters | $1.43K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.